Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunoprophylaxis with Simulect (basiliximab) in kidney transplantation: results from routine clinical practice at 18 kidney transplant units.
Rengel M, Fernández Rodriguez A, Gómez Huertas E, Plaza JJ, Ruiz San Millán JC, Oppenheimer F, Bustamante J, Checa D, Sanchez Plumed JA, García Pérez J, Sanz Guajardo A, Llorente S, Martin Govantes JA, Gentil MA, Gomez Ullate P, Sanchez Guisande D, Puig JM, Fernández C. Rengel M, et al. Transplant Proc. 2003 Aug;35(5):1691-3. doi: 10.1016/s0041-1345(03)00575-x. Transplant Proc. 2003. PMID: 12962760
A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function.
Andrés A, Marcén R, Valdés F, Plumed JS, Solà R, Errasti P, Lauzurica R, Pallardó L, Bustamante J, Amenábar JJ, Plaza JJ, Gómez E, Grinyó JM, Rengel M, Puig JM, Sanz A, Asensio C, Andrés I; NI2A Study Group. Andrés A, et al. Among authors: rengel m. Clin Transplant. 2009 Jan-Feb;23(1):23-32. doi: 10.1111/j.1399-0012.2008.00891.x. Epub 2008 Sep 16. Clin Transplant. 2009. PMID: 18798851 Clinical Trial.
Cancer after renal transplantation.
Anaya F, Plaza J, Sanz-Guajardo D, Luque A, Rengel M, Fernández J, Moreno M. Anaya F, et al. Among authors: rengel m. Transplant Proc. 2003 Mar;35(2):697-9. doi: 10.1016/s0041-1345(03)00051-4. Transplant Proc. 2003. PMID: 12644098 No abstract available.
Use of the new proliferation signal inhibitor everolimus in renal transplant patients in Spain: preliminary results of the EVERODATA registry.
Ruiz JC, Sánchez A, Rengel M, Beneyto I, Plaza JJ, Zárraga S, Errasti P, Andrés A, Morales JM, Torregrosa JV, Alarcón A, Morey A, Romero R, Fernández A, Díaz JM, Cantarell C; EVERODATA Group. Ruiz JC, et al. Among authors: rengel m. Transplant Proc. 2007 Sep;39(7):2157-9. doi: 10.1016/j.transproceed.2007.07.071. Transplant Proc. 2007. PMID: 17889123
Controlled randomized study comparing the cardiovascular profile of everolimus with tacrolimus in renal transplantation.
Cruzado JM, Pascual J, Sánchez-Fructuoso A, Serón D, Díaz JM, Rengel M, Oppenheimer F, Hernández D, Paravisini A, Saval N, Morales JM; Evita Study Group. Cruzado JM, et al. Among authors: rengel m. Transpl Int. 2016 Dec;29(12):1317-1328. doi: 10.1111/tri.12862. Epub 2016 Oct 17. Transpl Int. 2016. PMID: 27648523 Free article. Clinical Trial.
56 results